Search results
24 kwi 2019 · Sensitivities for cancer were 46.1% for CRP, 43.6% ESR and 49.7% for PV. Cancer should be considered in patients with raised inflammatory markers.
A high CRP was associated with higher mortality in 90% of reports in people with solid tumors primary sites. This was particularly notable in GI malignancies and kidney malignancies. In other solid tumors (lung, pancreas, hepatocellular cancer, and bladder) an elevated CRP also predicted prognosis.
The aim of this report is to address the issue of when, if ever, it is appropriate to concurrently test ESR and CRP (as opposed to testing only ESR or CRP) to help diagnose inflammatory disease or serious infection.
C-Reactive Protein (CRP), a cheap and sensitive marker of inflammation may help. This study investigated the relationship between CRP and prognosis in a large cohort of solid tumors with mixed cancer diagnoses and stages.
Objective: A thorough understanding of the similarities and differences between these two serological markers, including factors that affect measurements, is necessary for the proper utilization and interpretation of ESR and CRP.
12 kwi 2020 · Our aim was to compare the clinical significance of serum C-reactive protein (CRP) level and erythrocyte sedimentation rate (ESR) between 3 most frequently seen cancer types (gastric, lung and...
Comparative value of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) testing in combination versus individually for the diagnosis of undifferentiated patients with suspected inflammatory disease or serious infection: a systematic review and economic analysis.
